Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Mateon Therapeutics (United States) | Researchclopedia

Back to institutions

Mateon Therapeutics (United States)

South San Franciscocompany

48

Works

3,012

Citations

24

h-index

Top Research Topics

Hippo pathway signaling and YAP/TAZ Angiogenesis and VEGF in Cancer Synthesis and biological activity

Top Researchers

John C. Burnett Mayo Clinic

994 works41,455 citationsh-index: 103

Recent Research

Early-activated extracellular matrix proteins shape the metabolic and spatial dynamics of the kidney fibrotic microenvironment

Yuan Gui,Wenxue Li,et al.

20260 citations

Cellular Mechanics and Interactions

Ubiquitin and proteasome pathways

COVID-19 Pandemic Impacts

COVID-19 epidemiological studies

Renal cell carcinoma treatment

Migraine and Headache Studies

Ovarian cancer diagnosis and treatment

HER2/EGFR in Cancer Research

Wnt/β-catenin signaling in development and cancer

Carol Aghajanian Memorial Sloan Kettering Cancer Center

777 works34,694 citationsh-index: 86

Fatih M. Uckun University of Southern California

752 works22,135 citationsh-index: 74

Mauro Ferrari University of Pisa

861 works18,123 citationsh-index: 59

Michael J. Koren Far Eastern Scientific Centre of Physiology and Pathology of Respiration Russian Academy of Medical Sciences

152 works14,708 citationsh-index: 47

Steven R. Goldsmith Hennepin County Medical Center

182 works13,329 citationsh-index: 43

SAFETY AND EARLY EFFICACY OF VT3989, A TEAD INHIBITOR, IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): A PHASE I/II STUDY

Candace L. Haddox,Mrinal M. Gounder,et al.

20250 citations

Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas

Maxwell T. Laws,Deepak Bhatt,et al.

20250 citations

DDDR-14. TEAD inhibitor VT3989, in combination with Brigatinib prevents <i>NF2</i> -deficient meningioma and schwannoma growth

Jim F. Blake,Elliot Kearney,et al.

20250 citations

YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial

Timothy A. Yap,David J. Kwiatkowski,et al.

202517 citations

Targeting the Hippo pathway in cancer

Kieran F. Harvey,Tracy T. Tang

202523 citations